Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Griese

Showing results (251-260 of 280) with videos related to

Pageof 28
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 10, 2025
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A Phase 3, Open-Label Extension StudyCori L Daines, Deepika Polineni, Elizabeth Tullis, et al.
Clinical and Experimental Pediatrics|June 19, 2026
Telomere biology disorders associated with childhood interstitial lung diseaseMaria Greiner-Mai, Christina Katharina Rapp, Katrin Knoflach, et al.
The American Journal of Pathology|November 29, 2023
Multilamellated Basement Membranes in the Capillary Network of Alveolar Capillary DysplasiaJan C Kamp, Lavinia Neubert, Jonas C Schupp, et al.
The European Respiratory Journal|November 9, 2023
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one <i>F508del</i> allele: 144-week interim results from a 192-week open-label extension studyCori L Daines, Elizabeth Tullis, Stefano Costa, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2024
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision MedicineAyodeji Adegunsoye, Jonathan A Kropski, Juergen Behr, et al.
The European Respiratory Journal|June 21, 2022
European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trialsAnne B Chang, Angela Zacharasiewicz, Vikas Goyal, et al.
Nature Genetics|April 22, 2014
Mutations in CCNO result in congenital mucociliary clearance disorder with reduced generation of multiple motile ciliaJulia Wallmeier, Dalal A Al-Mutairi, Chun-Ting Chen, et al.
Journal of Medical Genetics|April 10, 2014
Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrumAnne Thorwarth, Sarah Schnittert-Hübener, Pamela Schrumpf, et al.
Ebiomedicine|March 1, 2025
Bi-allelic LAMP3 variants in childhood interstitial lung disease: a surfactant-related diseaseCamille Louvrier, Tifenn Desroziers, Yohan Soreze, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 7, 2026
Biallelic LAMP3 Variants in Five Families with Interstitial Lung Disease: Evidence of a Disease-Gene AssociationLaura A Keehan, Hitomi Ono-Minagi, Mohamad Hadhud, et al.
Pageof 28

Showing results (251-260 of 280) with videos related to

Sort By:
Pageof 28
American Journal of Respiratory and Critical Care Medicine|April 10, 2025
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A Phase 3, Open-Label Extension StudyCori L Daines, Deepika Polineni, Elizabeth Tullis, et al.
Clinical and Experimental Pediatrics|June 19, 2026
Telomere biology disorders associated with childhood interstitial lung diseaseMaria Greiner-Mai, Christina Katharina Rapp, Katrin Knoflach, et al.
The American Journal of Pathology|November 29, 2023
Multilamellated Basement Membranes in the Capillary Network of Alveolar Capillary DysplasiaJan C Kamp, Lavinia Neubert, Jonas C Schupp, et al.
The European Respiratory Journal|November 9, 2023
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one <i>F508del</i> allele: 144-week interim results from a 192-week open-label extension studyCori L Daines, Elizabeth Tullis, Stefano Costa, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2024
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision MedicineAyodeji Adegunsoye, Jonathan A Kropski, Juergen Behr, et al.
The European Respiratory Journal|June 21, 2022
European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trialsAnne B Chang, Angela Zacharasiewicz, Vikas Goyal, et al.
Nature Genetics|April 22, 2014
Mutations in CCNO result in congenital mucociliary clearance disorder with reduced generation of multiple motile ciliaJulia Wallmeier, Dalal A Al-Mutairi, Chun-Ting Chen, et al.
Journal of Medical Genetics|April 10, 2014
Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrumAnne Thorwarth, Sarah Schnittert-Hübener, Pamela Schrumpf, et al.
Ebiomedicine|March 1, 2025
Bi-allelic LAMP3 variants in childhood interstitial lung disease: a surfactant-related diseaseCamille Louvrier, Tifenn Desroziers, Yohan Soreze, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 7, 2026
Biallelic LAMP3 Variants in Five Families with Interstitial Lung Disease: Evidence of a Disease-Gene AssociationLaura A Keehan, Hitomi Ono-Minagi, Mohamad Hadhud, et al.
Pageof 28